Mauna Kea Technologies S.A.

Established in 2000 and headquartered in Paris, France, Mauna Kea Technologies S.A. develops and commercializes medical devices across a broad international footprint, encompassing Europe, the Middle East, Africa, the United States, Latin America, and Asia. Its core focus is on developing and distributing innovative instruments for real-time visualization and identification of cellular anomalies during routine gastrointestinal and pulmonary endoscopic procedures. The company's premier offering, Cellvizio, is a sophisticated confocal miniprobe endomicroscopy system that provides clinicians and researchers with ultra-high-resolution images of tissues at a cellular level.